89307-3
Naloxone-3-glucuronide [Presence] in Urine by Screen method
Active
Part Description
LP266980-4 Naloxone-3-glucuronide
Naloxone is a pure opioid antagonist and, when taken at recommended doses, has no physiological effects in the absence of an opioid agonist. Intravenous naloxone becomes effective within two minutes of injection, but oral or sublingual naloxone has little effect due to its poor absorption. Therefore, intravenous naloxone is used to treat opioid overdose, and it is used as a sublingual combination with buprenorphine, an opioid agonist-antagonist used to treat chronic opioid-dependence, to lower buprenorphine's abuse potential as follows: when the combination is taken sublingually as prescribed, naloxone exerts little effect and buprenorphine's effects predominate; however, if crushed and injected intravenously, naloxone's antagonist properties reverse the agonist effects of buprenorphine and can precipitate withdrawal. PMID: 19368419 Nalaxone levels along with its inactive metabolite, naloxone-3-glucuronide (N3G), may be measured to monitor compliance or identify illicit opioid drug use.
Source: Regenstrief LOINC,
PMID: 19368419
LOINC Names Get Info
- Fully-Specified Name
- Naloxone-3-glucuronide:
PrThr: Pt: Urine: Ord: Screen - Long Common Name
- Naloxone-3-glucuronide [Presence] in Urine by Screen method
- Short Name
- Naloxone-3G Ur Ql Scn
- Display Name
- Naloxone-3-glucuronide Screen Ql (U)
- Consumer Name Alpha Get Info
- Naloxone-3-glucuronide, Urine
Part Model Get Info
- Component
- Naloxone-3-glucuronide
LP266980-4
- Analyte
- Naloxone-3-glucuronide
LP266980-4
- Component Numerator
- Naloxone-3-glucuronide
LP266980-4
- Component Numerator Core
- Naloxone-3-glucuronide
LP266980-4
- Component Numerator Core Suffix
- NULL
- Component Denominator
- NULL
- Component Denominator Core
- NULL
- Component Denominator Core Suffix
- NULL
- Challenge
- NULL
- Adjustment
- NULL
- Count
- NULL
- Property
- PrThr
LP217195-9
- Time
- Pt
LP6960-1
- Time Core
- Pt
LP6960-1
- Time Modifier
- NULL
- System
- Urine
LP7681-2
- System Core
- Urine
LP7681-2
- Super System
- NULL
- Scale
- Ord
LP7751-3
- Method
- Screen
LP6503-9
Example Answer List: LL744-4
Source: Regenstrief Institute| Answer | Code | Score | Answer ID |
|---|---|---|---|
| Detected | LA11882-0 | ||
| Not detected | LA11883-8 |
Basic Attributes
- Class
- DRUG/TOX
- Type
- Laboratory
- First Released
- Version 2.64
- Last Updated
- Version 2.70 (MIN)
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 95796-9 | Opioids panel - Urine by Screen method |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| cs-CZ | Czech (Czechia) | Naloxon-3-glukuronid: |
| el-GR | Greek (Greece) | Ναλοξόνη-3-γλυκουρονίδιο: Synonyms: DRUG/TOX Ord PrThr Pt Έλεγχος Ναλοξόνη Ναλοξόνη-3-γλυκουρονίδιο Ούρα |
| es-ES | Spanish (Spain) | Naloxona-3-glucurónido: |
| es-MX | Spanish (Mexico) | Naloxona-3-glucurónido: |
| fr-FR | French (France) | Naloxone-3-glucuronide: |
| it-IT | Italian (Italy) | Naloxone-3-glucuronide: Synonyms: Livelli farmacologici e tossicologia Presenza o Soglia Punto nel tempo (episodio) Screening tossicologico |
| pl-PL | Polish (Poland) | Nalokson-3-glukuronid: |
| zh-CN | Chinese (China) | 钠洛酮-3-葡糖苷酸: Synonyms: Ⅲ C19H21NO4; |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
LOINC Copyright
Copyright © Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://